Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

DexLab

DexLab
PRIVATE STATUS
Seed LATEST DEAL TYPE (Cancelled)
$167K LATEST DEAL AMOUNT
1 INVESTORS
Description

Developer of a technology that allows to produce dextran from natural waste. The company achieves this process by using molasses and milk whey.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Commercial Services
Other Industries
Other Healthcare
Primary Office
  • Latvia
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore DexLab’s full profile, request a free trial.

DexLab Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 06-Nov-2015 $167K Cancelled Startup
1. Accelerator/Incubator 14-Oct-2015 000.00 000.00 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

DexLab Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Commercialization Reactor Accelerator/Incubator Minority 000 0000 000000 0

DexLab Executive Team (1)

Name Title Board
Seat
Contact
Info
Dmitrijs Kononovs Chief Executive Officer